6876 - 6900 of 8436 Results
Title
Year
-
OPENTitle: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brainJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 26End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002Best OA location URL: https://doi.org/10.1016/j.nepig.2016.04.002Citation Count: 11
-
RESTRICTEDTitle: Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 45Issue #:Start Page: 212.e13End Page: 212.e17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.04.023Best OA location URL: http://hdl.handle.net/20.500.11794/13593Citation Count: 48
- How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?2016RESTRICTEDTitle: How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?Journal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 131End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13627Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13627Citation Count: 81
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial2016OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 86
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action2016RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
- Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration2016OPENTitle: Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regenerationJournal Name: Acta BiomaterialiaPublisher: Elsevier BVVol: 38Issue #:Start Page: 44End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.actbio.2016.04.021Best OA location URL: https://europepmc.org/articles/pmc5457669?pdf=renderCitation Count: 80
- Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy2016OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://europepmc.org/articles/pmc4899947?pdf=renderCitation Count: 3
-
RESTRICTEDTitle: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 28Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027Citation Count: 157
-
OPENTitle: Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum DisorderJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 2627End Page: 2637Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/npp.2016.64Best OA location URL: https://www.nature.com/articles/npp201664.pdfCitation Count: 139
-
RESTRICTEDTitle: Technology in Parkinson's disease: Challenges and opportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1272End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26642Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/9b88ef9a-46cf-56a6-adcc-40327184fd3c/downloadCitation Count: 477
- shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity2016OPENTitle: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and ToxicityJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e1005995End Page: e1005995Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1005995Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1005995&type=printableCitation Count: 78
- A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid2016OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 5
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort2016OPENTitle: The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 924End Page: 932Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.26613Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.26613Citation Count: 53
- Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor2016OPENTitle: Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitorJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 8Start Page: 2894End Page: 2903Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23213Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945383Citation Count: 37
-
RESTRICTEDTitle: Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 8Start Page: 1192End Page: 1202Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26614Citation Count: 111
- Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease2016OPENTitle: Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s DiseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0097-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0097-0Citation Count: 69
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/61098/6/Guella_et%20al_2018%2bSuppl.pdfCitation Count: 92
- A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging2016OPENTitle: A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 134Issue #:Start Page: 658End Page: 670Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.04.001Best OA location URL: https://europepmc.org/articles/pmc4912927?pdf=renderCitation Count: 85
- Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program2016OPENTitle: Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy programJournal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 17Issue #: 3Start Page: 361End Page: 375Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10561-016-9555-8Best OA location URL: https://europepmc.org/articles/pmc5026224?pdf=renderCitation Count: 68
- Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders2016OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564/file/Pineau_2016_Executive.pdfCitation Count: 15
-
RESTRICTEDTitle: MRI biomarkers — a precision medicine tool in neurology?Journal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 6Start Page: 323End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2016.51Best OA location URL: https://europepmc.org/articles/pmc5512159?pdf=renderCitation Count: 8
-
OPENTitle: Clinical-genetic model predicts incident impulse control disorders in Parkinson's diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 10Start Page: 1106End Page: 1111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-312848Best OA location URL: http://doi.org/10.1136/jnnp-2015-312848Citation Count: 108
- Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)2016OPENTitle: Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)Journal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1192End Page: 1200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035Best OA location URL: https://europepmc.org/articles/pmc5031509?pdf=renderCitation Count: 44
-
OPENTitle: Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal agingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 5Start Page: 399End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.309Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.309Citation Count: 64
-
OPENTitle: Mild cognitive impairment in Parkinson's disease versus Alzheimer's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 27Issue #:Start Page: 54End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.007Best OA location URL: https://europepmc.org/articles/pmc4887313?pdf=renderCitation Count: 27